Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
16901901000001117 | Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
37721601000001111 | Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Is a | Product containing precisely triamcinolone acetonide 1 milligram/1 gram conventional release oromucosal paste | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has dispensed dose form | Paste | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has active ingredient | Triamcinolone acetonide | false | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has manufactured dose form | Drug paste | false | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Is a | Adcortyl in Orabase | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has specific active ingredient | Triamcinolone acetonide | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has dispensed dose form | Drug paste | false | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | VMP non-availability indicator | Not available | false | Inferred relationship | Existential restriction modifier | ||
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | VMP non-availability indicator | Re-introduced | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) 5 gram | Is pack of | False | Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Inferred relationship | Existential restriction modifier | |
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) 5 gram | Has AMP | True | Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets